A detailed history of Financial Advisory Service, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 24,788 shares of ABBV stock, worth $4.46 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
24,788
Previous 23,980 3.37%
Holding current value
$4.46 Million
Previous $4.11 Million 19.01%
% of portfolio
0.41%
Previous 0.37%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $132,382 - $161,058
808 Added 3.37%
24,788 $4.9 Million
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $146,276 - $170,818
945 Added 4.1%
23,980 $4.11 Million
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $93,015 - $105,982
582 Added 2.59%
23,035 $4.19 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $86,000 - $96,856
625 Added 2.86%
22,453 $3.48 Million
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $74,142 - $85,830
555 Added 2.61%
21,828 $3.25 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $134,497 - $167,373
1,015 Added 5.01%
21,273 $2.87 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $287,484 - $331,081
-1,988 Reduced 8.94%
20,258 $3.23 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $260,852 - $312,830
1,886 Added 9.26%
22,246 $3.6 Million
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $374,714 - $429,772
2,792 Added 15.89%
20,360 $2.73 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $333,315 - $423,753
2,422 Added 15.99%
17,568 $2.69 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $216,183 - $268,222
1,638 Added 12.13%
15,146 $2.46 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $223,991 - $283,414
2,085 Added 18.25%
13,508 $1.83 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $45,220 - $51,331
425 Added 3.86%
11,423 $1.23 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $123,516 - $137,604
1,174 Added 11.95%
10,998 $1.24 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $114,269 - $125,796
1,117 Added 12.83%
9,824 $1.06 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $96,588 - $130,404
1,200 Added 15.99%
8,707 $933,000
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $38,058 - $44,667
443 Added 6.27%
7,507 $658,000
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $80,560 - $107,801
1,098 Added 18.4%
7,064 $694,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $193,177 - $292,881
2,995 Added 100.81%
5,966 $455,000
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $214,298 - $268,132
2,971 New
2,971 $263,000
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $186,850 - $238,839
-2,844 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $10,645 - $12,529
-138 Reduced 4.63%
2,844 $229,000
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $11,755 - $14,497
-151 Reduced 4.82%
2,982 $275,000
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $711 - $790
8 Added 0.26%
3,133 $296,000
Q2 2018

Jul 26, 2018

BUY
$89.78 - $106.23 $628 - $743
7 Added 0.22%
3,125 $290,000
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $17,113 - $22,917
-186 Reduced 5.63%
3,118 $295,000
Q4 2017

Jan 29, 2018

SELL
$89.56 - $98.21 $7,791 - $8,544
-87 Reduced 2.57%
3,304 $319,000
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $236,861 - $302,545
3,391
3,391 $301,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.